COVID: Phase 1 pharmacokinetic profile supports the potential for ratutrelvir to be dosed as a once-a-day, single drug, 10-day treatment course, ...

BOTHELL, Wash., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the three and nine months ended September 30, 2024, ...

Over the last few years, the SARS-CoV-2 virus, responsible for COVID-19, has undergone significant changes, evolving from the original wild-type strains to the highly transmissible Omicron variant.

A total of 135,230 patients with clinical stage III or IV cancer (mean age, 62.94 years; 45.1% women) who received antineoplastic medications between January 2019 and June 2021 were included in the ...

Center for 4D cellular dynamics, Department of Chemistry, University of Copenhagen, Copenhagen 2100 Denmark Novo Nordisk Challenge Center for Optimised Oligo Escape and Control of Disease, Copenhagen ...

In this study, we identified that the recruitment of ubiquitin-specific protease USP-50/USP8 to EEs requires Rabex5. Instead of stabilizing Rabex5, the USP-50/USP8 recruitment dissociates Rabex5 from ...

The new form of antibiotics is designed to target a naturally occurring enzyme—caseinolytic protease proteolytic subunit, ClpP, for short—which chews up old or defective proteins and plays an ...

The 1:1 ratio results from the way the X and Y chromosomes are doled out in sperm and eggs. We know that boys and girls are produced in much the same frequency. But how – and why – is this 1:1 ...